These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 19410441

  • 21. Utilization of inhaled corticosteroids for infants with bronchopulmonary dysplasia.
    Slaughter JL, Stenger MR, Reagan PB, Jadcherla SR.
    PLoS One; 2014; 9(9):e106838. PubMed ID: 25192252
    [Abstract] [Full Text] [Related]

  • 22. Assessment of Postnatal Corticosteroids for the Prevention of Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Network Meta-analysis.
    Ramaswamy VV, Bandyopadhyay T, Nanda D, Bandiya P, Ahmed J, Garg A, Roehr CC, Nangia S.
    JAMA Pediatr; 2021 Jun 01; 175(6):e206826. PubMed ID: 33720274
    [Abstract] [Full Text] [Related]

  • 23. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial.
    Baud O, Maury L, Lebail F, Ramful D, El Moussawi F, Nicaise C, Zupan-Simunek V, Coursol A, Beuchée A, Bolot P, Andrini P, Mohamed D, Alberti C, PREMILOC trial study group.
    Lancet; 2016 Apr 30; 387(10030):1827-36. PubMed ID: 26916176
    [Abstract] [Full Text] [Related]

  • 24. Inhaled Corticosteroids for Bronchopulmonary Dysplasia: A Meta-analysis.
    Shinwell ES, Portnov I, Meerpohl JJ, Karen T, Bassler D.
    Pediatrics; 2016 Dec 30; 138(6):. PubMed ID: 27940717
    [Abstract] [Full Text] [Related]

  • 25. Corticosteroids in the prevention and treatment of infants with bronchopulmonary dysplasia: Part II. Inhaled corticosteroids alone or in combination with surfactants.
    Szabó H, Baraldi E, Colin AA.
    Pediatr Pulmonol; 2022 Apr 30; 57(4):787-795. PubMed ID: 34964564
    [Abstract] [Full Text] [Related]

  • 26. Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation: A Randomized Clinical Trial.
    Onland W, Cools F, Kroon A, Rademaker K, Merkus MP, Dijk PH, van Straaten HL, Te Pas AB, Mohns T, Bruneel E, van Heijst AF, Kramer BW, Debeer A, Zonnenberg I, Marechal Y, Blom H, Plaskie K, Offringa M, van Kaam AH, STOP-BPD Study Group.
    JAMA; 2019 Jan 29; 321(4):354-363. PubMed ID: 30694322
    [Abstract] [Full Text] [Related]

  • 27. Policy statement--postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia.
    Watterberg KL, American Academy of Pediatrics. Committee on Fetus and Newborn.
    Pediatrics; 2010 Oct 29; 126(4):800-8. PubMed ID: 20819899
    [Abstract] [Full Text] [Related]

  • 28. Respiratory and systemic effects of inhaled dexamethasone on ventilator dependant preterm infants at risk for bronchopulmonary dysplasia.
    Pappagallo M, Abbasi S, Bhutani VK.
    Indian J Pediatr; 1998 Oct 29; 65(2):273-82. PubMed ID: 10771973
    [Abstract] [Full Text] [Related]

  • 29. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: study protocol for the international, multicenter, randomized PLUSS trial.
    Manley BJ, Kamlin COF, Donath S, Huang L, Birch P, Cheong JLY, Dargaville PA, Dawson JA, Doyle LW, Jacobs SE, Wilson R, Davis PG, McKinlay CJD.
    Trials; 2023 May 09; 24(1):320. PubMed ID: 37161488
    [Abstract] [Full Text] [Related]

  • 30. Intratracheal Administration of Budesonide-Surfactant in Prevention of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: A Systematic Review and Meta-Analysis.
    Venkataraman R, Kamaluddeen M, Hasan SU, Robertson HL, Lodha A.
    Pediatr Pulmonol; 2017 Jul 09; 52(7):968-975. PubMed ID: 28165675
    [Abstract] [Full Text] [Related]

  • 31. Postnatal corticosteroid use for prevention or treatment of bronchopulmonary dysplasia in England and Wales 2012-2019: a retrospective population cohort study.
    Yao S, Uthaya S, Gale C, Modi N, Battersby C, UK Neonatal Collaborative (UKNC).
    BMJ Open; 2022 Nov 17; 12(11):e063835. PubMed ID: 36396314
    [Abstract] [Full Text] [Related]

  • 32. [Bronchopulmonary dysplasia and corticosteroid therapy].
    Chérif A, Marrakchi Z, Chaouachi S, Boukef S, Sfar R.
    Arch Pediatr; 2002 Feb 17; 9(2):159-68. PubMed ID: 11915499
    [Abstract] [Full Text] [Related]

  • 33. Postnatal hydrocortisone for preventing or treating bronchopulmonary dysplasia in preterm infants: a systematic review.
    Doyle LW, Ehrenkranz RA, Halliday HL.
    Neonatology; 2010 Feb 17; 98(2):111-7. PubMed ID: 20150750
    [Abstract] [Full Text] [Related]

  • 34. Long-term effects of postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia: Balancing the risks and benefits.
    Cheong JLY, Doyle LW.
    Semin Fetal Neonatal Med; 2019 Jun 17; 24(3):197-201. PubMed ID: 30962159
    [Abstract] [Full Text] [Related]

  • 35. Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone.
    Ballabh P, Simm M, Kumari J, Califano C, Aghai Z, Laborada G, Sison C, Cunningham-Rundles S.
    Pediatr Pulmonol; 2003 May 17; 35(5):392-9. PubMed ID: 12687597
    [Abstract] [Full Text] [Related]

  • 36. Postnatal corticosteroids for preterm infants--do what we say, not what we do.
    Jobe AH.
    N Engl J Med; 2004 Mar 25; 350(13):1349-51. PubMed ID: 15044647
    [No Abstract] [Full Text] [Related]

  • 37. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.
    McEvoy C, Bowling S, Williamson K, McGaw P, Durand M.
    Pediatr Pulmonol; 2004 Jul 25; 38(1):55-63. PubMed ID: 15170874
    [Abstract] [Full Text] [Related]

  • 38. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.
    Halliday HL, Ehrenkranz RA.
    Cochrane Database Syst Rev; 2000 Jul 25; (2):CD001145. PubMed ID: 10796251
    [Abstract] [Full Text] [Related]

  • 39. Current Concepts of Corticosteroids Use for the Prevention of Bronchopulmonary Dysplasia.
    Perrone S, Orlando S, Petrolini C, Marinelli F, Moretti S, Corradi M, Giordano M, De Bernardo G.
    Curr Pediatr Rev; 2023 Jul 25; 19(3):276-284. PubMed ID: 36043724
    [Abstract] [Full Text] [Related]

  • 40. Randomized Trial of 42-Day Compared with 9-Day Courses of Dexamethasone for the Treatment of Evolving Bronchopulmonary Dysplasia in Extremely Preterm Infants.
    Marr BL, Mettelman BB, Bode MM, Gross SJ.
    J Pediatr; 2019 Aug 25; 211():20-26.e1. PubMed ID: 31349916
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.